Voyager Therapeutics stock trades at EUR 1.61 on Tuesday

Published on 11/03/2026 at 13:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Voyager Therapeutics stock has scheduled two Alzheimer presentations for mid-November. The events give investors a near-term clinical calendar item.

What Matters for Investors

Voyager Therapeutics is a biotechnology company focused on gene therapy development.
The company has scheduled two Alzheimer presentations for November 16 and 17, 2026.
The planned presentations provide a near-term event for investors tracking the company's clinical pipeline.

VYGR, US92915B1061, Illustration mit AI erstellt.

Voyager Therapeutics stock traded at EUR 1.61 on Lang & Schwarz at 13:30 CET on Tuesday, November 3, 2026. The quote gives investors an immediate market reference for the U.S. biotechnology company.

Investors can follow the real-time quote of Voyager Therapeutics stock on the company quote page.

Pipeline Event Comes Into View

Voyager Therapeutics has scheduled two Alzheimer presentations for November 16 and 17, 2026. The planned appearances give investors a near-term calendar item as they track the company's gene therapy programs.

For a development-stage biotechnology company, clinical presentations can shape expectations around research progress and future milestones. The event schedule alone, however, does not establish a change in valuation or clinical outcomes.

Quote Sets Immediate Reference

The Lang & Schwarz quote reflects the stock's euro trading reference during the European session. No Xetra comparison is included because the relevant Xetra closing price was not established for this report.